bracepharma.com
PortfolioBracePharma | BracePharma
http://www.bracepharma.com/portfolio
La Jolla, CA. Developing a new class of drug candidates, antibody-siRNA conjugates (ARCs. Website: www.aviditybiosciences.com/. Developing a new class of antiviral therapeutics for serious and chronic viral diseases. Website: www.cocrystalpharma.com. Developing novel therapeutics for life threatening fungal diseases. Website: www.f2g.com. Developing the next generation of inhaled nitric oxide (NO) products. Website: www.genollc.com. Creating novel therapeutics for cancer and immune disorders.
nlvpartners.com
New Leaf Venture Partners - Portfolio
http://www.nlvpartners.com/portfolio.html
With the success of our entrepreneurs our portfolio has. 20 billion-dollar companies, 34 acquired companies,. And 39 companies taken public, with more to come. Artificial intelligence platform that confirms medication adherence in clinical trials and high-risk patient populations. New York, NY. Platform for small-molecule drugs that induce targeted degradation of disease-causing intracellular proteins. New Haven, CT. NLV III / GROWTH. NLV III / GROWTH. NLV III / GROWTH. Berkeley Heights, NJ. New York, NY.
labcentral.org
Alumni Companies - LabCentral | Cambridge, MA
http://labcentral.org/resident-companies/alumni
LabCentral Houses Scientific Visionaries. Engaged in Early-Stage Research. LabCentral congratulates our alumni companies! View Company Graduated February 2016. View Company Graduated June 2015. View Company Graduated February 2016. View Company Graduated March 2016. View Company Graduated August 2015. View Company Graduated March 2015. View Company Graduated July 2016. View Company Graduated March 2015. View Company Graduated April 2015. View Company Graduated February 2015. 700 Main Street, North.
SOCIAL ENGAGEMENT